Cardium Therapeutics, Inc. (CXM) Swings to Q4 Loss
Tweet
Share
E-mailGet Alerts CXM Hot Sheet
Price: $7.13 +3.18%
Financial Fact:
Total operating expenses: 1.19M
Today's EPS Names:
JAGX, CLIR, ZTO, More
Financial Fact:
Total operating expenses: 1.19M
Today's EPS Names:
JAGX, CLIR, ZTO, More
Join SI Premium – FREE
Cardium Therapeutics, Inc. (AMEX: CXM) reported Q4 EPS of ($0.02), versus $0.01 reported last year.
For earnings history and earnings-related data on Cardium Therapeutics, Inc. (CXM) click here.
For earnings history and earnings-related data on Cardium Therapeutics, Inc. (CXM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
- Exyn Technologies, Inc. (EXYN) Reports Q2 Loss of $1.55
- FOMC minutes from July 28-29th meeting
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
